skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Trivalent Live-Attenuated Influenza Vaccine (Code C101094)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Trivalent Live-Attenuated Influenza Vaccine

Definition: A weakened live virus vaccine containing three seasonal influenza reassortants with prophylactic activity against influenza subtypes A and B. The trivalent live-attenuated influenza vaccine (LAIV) contains 2 strains of the influenza subtype A, one for H1N1 and one for H3N2, and one strain of subtype B. Upon intranasal administration by sprayer of the trivalent LAIV, the live viruses replicate in the upper respiratory tract and induce an immune response leading to active immunization against influenza subtypes A and B.

Label: Trivalent Live-Attenuated Influenza Vaccine

NCI Thesaurus Code: C101094 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1456404  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Trivalent Intranasal Influenza Vaccine, Live
Trivalent Live-Attenuated Influenza Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 729102
PDQ Open Trial Search ID 729102 (check for NCI PDQ open clinical trial info)
UMLS CUI C1456404

Other Properties:
     Name Value (qualifiers indented underneath)
code C101094
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom